In this study on 130 cases of advanced BC, CCN5 and ER were expressed in normal breast tissue, DCIS tissue, and invasive carcinoma tissue, with CCN5 showing a low–high-low expression pattern. Here, CCN5 is linked to ductal breast carcinoma in situ.